查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509600

2024 年心臟再同步治療 (CRT) 全球市場報告

Cardiac Resynchronization Therapy Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

心臟再同步治療（CRT）市場規模預計在未來幾年將強勁成長。預計到 2028 年將以 6.9% 的複合年成長率成長至 82.2 億美元。預測期內的預期成長是由於心臟衰竭和心臟疾病的盛行率不斷上升、老年人口的增加、心血管疾病盛行率的上升、對 CRT 治療以及心律調節器和心臟去顫器治療的持續需求造成的，這是由多種因素造成的，包括：治療方面的進步以及對 CRT 治療的認知的提高。預測期內預計的主要趨勢包括採用 CRT-D 設備取代傳統心律調節器、先進技術的整合、CRT 治療的擴展、人工智慧的結合、機器學習技術的採用等。

心血管疾病盛行率的增加可能在未來幾年推動心臟再同步治療（CRT）市場的擴張。心血管疾病（CVD）包括影響心臟和血管的多種疾病，與人口老化、不健康的生活方式、吸煙增加、久坐的生活方式和不良飲食習慣等因素有關，這些因素導致患病率上升。 CRT 透過同步電脈衝增強心臟收縮的協調性，在心臟衰竭等心血管疾病的治療中發揮重要作用。例如，根據美國疾病管制與預防中心報告，美國死於心臟病的人數從2020年的690,882人增加到2021年的695,000人。

醫療保健支出的增加預計將進一步推動心臟再同步治療（CRT）市場的成長。衛生支出是指在特定時限內分配給衛生保健商品和服務的總資源，通常是在國家或機構層級。增加醫療保健投資將促進心臟再同步治療（CRT）的研究和開發工作，從而帶來技術進步、改善治療機會以及採取更全面的方法來實現個人和衛生系統的福祉。例如，根據英國國家統計局的數據，英國醫療保健支出名目英國9.4%，實際成長9.7%，2021年醫療保健支出總額達到3,672.5億美元（2,807億日圓）。其中包括 518.4 億美元（396 億英鎊）的藥品成本，以及預防性醫療成本，將大幅增加，到 2021 年將達到 459.3 億美元（351 億英鎊）。因此，醫療保健支出的激增正在推動心臟再同步治療（CRT）市場的成長。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 市場促進和限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年市場規模表現與成長
  • 市場規模預測與成長，2023-2028，2033F

第6章 市場細分

  • 全球心臟再同步治療 (CRT) 市場：按類型分類的表現和預測，2018-2023、2023-2028F、2033F
  • 心臟去顫器
  • 心律調節器
  • 全球心臟再同步治療 (CRT) 市場：按年齡分類的實際和預測，2018-2023、2023-2028F、2033F
  • 44歲以下
  • 45-64歲
  • 65-84歲
  • 85歲以上
  • 全球心臟再同步治療 (CRT) 市場：按最終用途分類的績效和預測，2018-2023、2023-2028F、2033F
  • 醫院
  • 心臟護理中心
  • 門診手術中心

第 7 章 區域/國家分析

  • 全球心臟再同步治療 (CRT) 市場：按地區分類的表現和預測，2018-2023、2023-2028F、2033F
  • 全球心臟再同步治療 (CRT) 市場：按國家、表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 心臟再同步治療（CRT）市場：競爭格局
  • 心臟再同步治療 (CRT) 市場：公司簡介
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • Biotronik SE & Co. KG

第31章 其他大型創新企業

  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Integer Holdings Corporation
  • Merit Medical Systems Inc.
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • Sorin Group
  • Berlin Heart GmbH
  • EBR Systems Inc.
  • Corvia Medical Inc.
  • Recor Medical
  • Jarvik Heart Inc.
  • Cardiac Dimensions Inc.
  • Farapulse Inc.
  • Osypka Medical GmbH
  • Japan Medical Device Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18097

Cardiac resynchronization therapy (CRT) is a treatment for heart failure aimed at synchronizing the contractions of the heart's ventricles. This therapy utilizes a biventricular pacemaker to administer electrical impulses to the heart muscle, thereby promoting a more coordinated rhythm of ventricular contractions. It has the potential to alleviate symptoms of heart failure, such as shortness of breath and fatigue, while also enhancing overall cardiac function.

The primary types of cardiac resynchronization therapy include cardiac resynchronization therapy (CRT)-defibrillator and cardiac resynchronization therapy (CRT)-pacemaker. A cardiac resynchronization therapy (CRT) defibrillator is a medical device designed to regulate heartbeats and deliver electrical shocks when irregular heart rhythms occur. These devices are utilized across various age groups, including patients below 44 years, 45-64 years, 65-84 years, and those aged above 85 years, by hospitals, cardiac care centers, and ambulatory surgical centers.

The cardiac resynchronization therapy market research report is one of a series of new reports from The Business Research Company that provides cardiac resynchronization therapy market statistics, including cardiac resynchronization therapy industry global market size, regional shares, competitors with a cardiac resynchronization therapy market share, detailed cardiac resynchronization therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac resynchronization therapy industry. This cardiac resynchronization therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac resynchronization therapy market size has grown strongly in recent years. It will grow from $5.89 billion in 2023 to $6.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The historical growth can be attributed to several factors, including the expansion of the geriatric population, a rise in the incidence of heart failure, increased investments in research and development for the innovation of CRT devices, heightened awareness about the therapy's benefits, physician training programs, and changes in the competitive landscape dynamics.

The cardiac resynchronization therapy market size is expected to see strong growth in the next few years. It will grow to $8.22 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of heart failure and cardiac disorders, the growth in the geriatric population, a higher incidence of cardiovascular diseases, the continued need for CRT therapy, advancements in pacemakers and defibrillator treatments, and the increasing awareness about CRT therapy. Major trends expected in the forecast period encompass the adoption of CRT-D devices over traditional pacemakers, the integration of advanced technology, the expansion of CRT therapy, the incorporation of artificial intelligence, and the adoption of machine learning techniques.

The rise in the prevalence of cardiovascular diseases is poised to drive the expansion of the cardiac resynchronization therapy (CRT) market in the future. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels, with factors such as aging populations, unhealthy lifestyles, increased tobacco usage, sedentary habits, and poor dietary choices contributing to their escalating prevalence. CRT plays a crucial role in managing cardiovascular diseases such as heart failure by enhancing the coordination of the heart's contractions through synchronized electrical impulses. For instance, as reported by the Centers for Disease Control and Prevention, the number of deaths from heart disease in the US increased from 690,882 in 2020 to 695,000 in 2021, underscoring the imperative for CRT's growth to address this trend.

The escalating healthcare expenditure is anticipated to further propel the growth of the cardiac resynchronization therapy market. Healthcare expenditure denotes the total resources allocated to healthcare goods and services within a specific timeframe, typically at a national or institutional level. Increased healthcare investment can foster research and development endeavors in cardiac resynchronization therapy, leading to technological advancements, enhanced therapy accessibility, and a more holistic approach to individual and healthcare system well-being. For example, according to the UK's Office for National Statistics, healthcare spending in the UK rose by 9.4% nominally and 9.7% in real terms, with total healthcare costs reaching $367.25 billion (£280.7 billion) in 2021. This included $51.84 billion (£39.6 billion) allocated to pharmaceutical expenses and a significant rise in preventative care spending, reaching $45.93 billion (£35.1 billion) in 2021. Hence, the surge in healthcare expenditure is a driving force behind the cardiac resynchronization therapy market's growth.

Leading companies in the cardiac resynchronization therapy market are concentrating on the development of implantable devices to enhance treatment outcomes for heart failure patients. Implantable devices in CRT synchronize the contractions of the heart's ventricles, improving pumping efficiency and managing heart failure symptoms. For instance, MicroPort Scientific Corporation launched the GALI SonR cardiac resynchronization therapy and defibrillation device (CRT-D) and the Navigo 4LV left ventricular pacing leads in Japan in February 2024. This innovative CRT-D device incorporates the first and only CRT hemodynamic sensor, designed to automatically optimize patients on a weekly basis, even during physical activity, thus ensuring real-life optimization. The clinically proven SonR algorithm has demonstrated a 35% reduction in the risk of heart failure hospitalization, contributing to the well-being and safety of CRT-D patients.

Major companies operating in the cardiac resynchronization therapy market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Integer Holdings Corporation, Merit Medical Systems Inc., LivaNova PLC, MicroPort Scientific Corporation, Sorin Group, Berlin Heart GmbH, EBR Systems Inc., Corvia Medical Inc., Recor Medical, Jarvik Heart Inc., Cardiac Dimensions Inc., Farapulse Inc., Osypka Medical GmbH, Japan Medical Device Corporation, Imricor Medical Systems Inc., Vascular Dynamics Inc., Svelte Medical Systems, Aleva Neurotherapeutics, BioSig Technologies Inc.

North America was the largest region in the cardiac resynchronization therapy market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac resynchronization therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac resynchronization therapy market consists of revenues earned by entities by providing services such as patient evaluation and diagnosis, device implantation procedures, device programming, follow-up care, management of complications, patient education, and collaborative care involving a multidisciplinary team. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac resynchronization therapy market also includes sales of pacemakers or defibrillators, leads, programmers, accessories, diagnostic tools, patient monitoring devices, and educational materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Resynchronization Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac resynchronization therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac resynchronization therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac resynchronization therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator; Cardiac Resynchronization Therapy (CRT)-Pacemaker
  • 2) By Age: Below 44 Years; 45-64 Years; 65-84 Years; Above 85 Years
  • 3) By End-Use: Hospitals; Cardiac Care Centers; Ambulatory Surgical Centers
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; Biotronik SE & Co. KG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Resynchronization Therapy Market Characteristics

3. Cardiac Resynchronization Therapy Market Trends And Strategies

4. Cardiac Resynchronization Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cardiac Resynchronization Therapy Market Size and Growth

  • 5.1. Global Cardiac Resynchronization Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiac Resynchronization Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiac Resynchronization Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac Resynchronization Therapy Market Segmentation

  • 6.1. Global Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiac Resynchronization Therapy (CRT)-Defibrillator
  • Cardiac Resynchronization Therapy (CRT)-Pacemaker
  • 6.2. Global Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Below 44 Years
  • 45-64 Years
  • 65-84 Years
  • Above 85 Years
  • 6.3. Global Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers

7. Cardiac Resynchronization Therapy Market Regional And Country Analysis

  • 7.1. Global Cardiac Resynchronization Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiac Resynchronization Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac Resynchronization Therapy Market

  • 8.1. Asia-Pacific Cardiac Resynchronization Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac Resynchronization Therapy Market

  • 9.1. China Cardiac Resynchronization Therapy Market Overview
  • 9.2. China Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac Resynchronization Therapy Market

  • 10.1. India Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac Resynchronization Therapy Market

  • 11.1. Japan Cardiac Resynchronization Therapy Market Overview
  • 11.2. Japan Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac Resynchronization Therapy Market

  • 12.1. Australia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac Resynchronization Therapy Market

  • 13.1. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac Resynchronization Therapy Market

  • 14.1. South Korea Cardiac Resynchronization Therapy Market Overview
  • 14.2. South Korea Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac Resynchronization Therapy Market

  • 15.1. Western Europe Cardiac Resynchronization Therapy Market Overview
  • 15.2. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac Resynchronization Therapy Market

  • 16.1. UK Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac Resynchronization Therapy Market

  • 17.1. Germany Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac Resynchronization Therapy Market

  • 18.1. France Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac Resynchronization Therapy Market

  • 19.1. Italy Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac Resynchronization Therapy Market

  • 20.1. Spain Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac Resynchronization Therapy Market

  • 21.1. Eastern Europe Cardiac Resynchronization Therapy Market Overview
  • 21.2. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac Resynchronization Therapy Market

  • 22.1. Russia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac Resynchronization Therapy Market

  • 23.1. North America Cardiac Resynchronization Therapy Market Overview
  • 23.2. North America Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac Resynchronization Therapy Market

  • 24.1. USA Cardiac Resynchronization Therapy Market Overview
  • 24.2. USA Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac Resynchronization Therapy Market

  • 25.1. Canada Cardiac Resynchronization Therapy Market Overview
  • 25.2. Canada Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac Resynchronization Therapy Market

  • 26.1. South America Cardiac Resynchronization Therapy Market Overview
  • 26.2. South America Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac Resynchronization Therapy Market

  • 27.1. Brazil Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac Resynchronization Therapy Market

  • 28.1. Middle East Cardiac Resynchronization Therapy Market Overview
  • 28.2. Middle East Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac Resynchronization Therapy Market

  • 29.1. Africa Cardiac Resynchronization Therapy Market Overview
  • 29.2. Africa Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac Resynchronization Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Resynchronization Therapy Market Competitive Landscape
  • 30.2. Cardiac Resynchronization Therapy Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Scientific Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Terumo Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Biotronik SE & Co. KG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cardiac Resynchronization Therapy Market Other Major And Innovative Companies

  • 31.1. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.2. Integer Holdings Corporation
  • 31.3. Merit Medical Systems Inc.
  • 31.4. LivaNova PLC
  • 31.5. MicroPort Scientific Corporation
  • 31.6. Sorin Group
  • 31.7. Berlin Heart GmbH
  • 31.8. EBR Systems Inc.
  • 31.9. Corvia Medical Inc.
  • 31.10. Recor Medical
  • 31.11. Jarvik Heart Inc.
  • 31.12. Cardiac Dimensions Inc.
  • 31.13. Farapulse Inc.
  • 31.14. Osypka Medical GmbH
  • 31.15. Japan Medical Device Corporation

32. Global Cardiac Resynchronization Therapy Market Competitive Benchmarking

33. Global Cardiac Resynchronization Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cardiac Resynchronization Therapy Market

35. Cardiac Resynchronization Therapy Market Future Outlook and Potential Analysis

  • 35.1 Cardiac Resynchronization Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Resynchronization Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Resynchronization Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer